Search

everythinglearnresearchcommunity

for

Search:↓

Skin symptoms can indicate endocrine disorders and have various treatments.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

The document provides a comprehensive index of medical and surgical topics, including hair removal, hair restoration, and various treatments for injuries and conditions.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

Voriconazole can cause serious side effects, especially in long-term use.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Model improves accuracy in predicting hair loss effects.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Improved nutrition quickly healed the patient's skin lesions.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.